Long-term safety of biologic and targeted synthetic disease modifying drugs in rheumatology

aFellow, Division of Rheumatology

bMedical Student, Department of Medicine

cAssistant Professor, Division of Rheumatology

dAdjunct Assistant Professor, Department of Epidemiology, University of Washington, Seattle, Washington, USA

Correspondence to Namrata Singh, MD, MSCI, 1959 NE Pacific Street, Section: Rheumatology, Seattle, WA 98195, USA. E-mail: [email protected]

留言 (0)

沒有登入
gif